Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study

Journal of Clinical Oncology

Volumn 23, Issue 25, 2005, Pages 5910-5917

  Fournel, Pierre ^a   Robinet, Gilles ^a   Thomas, Pascal ^a   Souquet, Pierre Jean ^a   Léna, Hervé ^a   Vergnenégre, Alain ^a   Delhoume, Jean Yves ^a   Le Treut, Jacques ^a   Silvani, Jules Antoine ^a   Dansin, Eric ^a   Bozonnat, Marie Cécile ^a   Daurés, Jean Pierre ^a   Mornex, Françoise ^a   Pérol, Maurice ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; NAVELBINE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE SEQUENCE; ESOPHAGITIS; ESOPHAGUS DISEASE; FEMALE; HUMAN; INFECTION; KIDNEY FAILURE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SEQUENTIAL ANALYSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; DRUG ADMINISTRATION; LUNG TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION DOSE FRACTIONATION; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 24944553737     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.070     Document Type: Article

References (28)

1. Pritchard RS, Anthony SP: Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer: A meta-analysis. Ann Intern Med 125:723-729, 1996
2. Marino P, Preatoni A, Cantoni A: Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb non-small cell lung cancer: A meta-analysis. Cancer 76:593-601, 1995
3. Non Small Cell Lung Cancer Collaborative Group: Chemotherapy in non small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311:899-909, 1995
4. Pfister DG, Johnson DH, Azzoli CG, et al: American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: Update 2003. J Clin Oncol 22:330-353, 2004
5. Bardet E, Moro-Sibilot D, Le Chevalier T, et al: Standards, options et recommandations pour le traitement des cancers broncho-pulmonaires non à petites cellules localement avancés. Bull Cancer 88:369-387, 2001
6. Dillman RO, Seagren SL, Propert KJ, et al: A randomized trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 323:940-945, 1990
7. Le Chevalier T, Arriagada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non small cell lung carcinoma: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417-423, 1991
8. Sause W, Kolesar P, Taylor S, et al: Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Radiation Therapy Oncology Group, Eastern Oncology Group and Southwest Oncology Group. Chest 117:358-364, 2000
9. Gaspar LE: Optimizing chemoradiation therapy approaches to unresectable stage III non-small cell lung cancer. Curr Opin Oncol 13:110-115, 2001
10. Clamon G, Herdnon J, Cooper R, et al: Randiosensitization with carboplatin for patients with unresectable stage III non-small cell lung cancer: A phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 17:4-11, 1999
11. Ball D, Bishop J, Smith J, et al: A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: Final report of an Australian multi-centre trial. Radiother Oncol 52:129-136, 1999
12. Friess G, Baikadi M, Harvey WH, et al: Concurrent cisplatin and etoposide with radiotherapy in locally advanced non-small cell lung cancer. Cancer Treat Rep 71:681-684, 1987
13. Shaw EG, McGinnis WL, Jett JR, et al: Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable non-small cell carcinoma of the lung. J Natl Cancer Inst 85:321-323, 1993
14. Lee JS, Scott R, Komaki R, et al: Concurrent chemo-radiation therapy with oral etoposide and cisplatin for locally advanced non-small cell lung cancer: Radiation Therapy Oncology Group Protocol 91-06. J Clin Oncol 14:1055-1064, 1996
15. Albain KS, Crowley JJ, Turrisi AT, et al: Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: A Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol 20: 3454-3460, 2002
16. Furuse K, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17:2692-2699, 1999
17. Curran WJ, Scott CB, Langer CJ et al: Long-term benefit is observed in a phase III comparaison of sequential vs concurrent chemo-radiation for patients with unresectable stage III nsclc: RTOG 94-10. Proc Am Soc Clin Oncol 22:621a, 2003 (abstr 2499)
18. Choy H, MacRae R: The current state of paclitaxel and radiation in the combined-modality therapy of non-small cell lung cancer. Semin Oncol 28:S17-S22, 2001 (suppl 4)
19. Vokes EE, Herndon JE, Crawford J, et al: Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non small cell lung cancer: Cancer and Leukemia Group B Study 9431. J Clin Oncol 20:4191-4198, 2002
20. Zatloukal PV, Petruzelka L, Zemanova M, et al: Concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin (V-P) in locally advanced non small cell lung cancer. A randomized phase II study. Proc Am Soc Clin Oncol 21:290a, 2002 (abstr 1159)
21. Perol M, Guérin JC, Thomas P, et al: Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. Lung Cancer 14:119-134, 1996
22. Miller A, Hoogstraten B, Staquet A, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
23. Le Chevalier T, Brisgand D, Douillard JY, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of an European multicenter trial including 612 patients. J Clin Oncol 12:360-367, 1994
24. Socinski MA, Rosenman JG, Halle J, et al: Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B non small cell lung carcinoma. Cancer 92:1213-1223, 2001
25. Leong SS, Tan EH, Fong KW, et al: Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non small cell lung cancer. J Clin Oncol 21:1767-1774, 2003
26. Movsas B, Scott C, Langer C, et al: Phase III study of amifostine in patients with locally advanced non small cell lung cancer (NSCLC) receiving chemotherapy and hyperfractionnated radiation (chemo/HFxRT): Radiation Therapy Oncology Group (RTOG) 98-01. Proc Am Soc Clin Oncol 22:636, 2003 (abstr 2559)
27. Gandara DR, Chansky K, Albain KS, et al: Consolidation docetaxel after concurrent chemo-radiotherapy in stage IIIB non-small cell lung cancer: Phase II Southwest Oncology Group Study S9504. J Clin Oncol 21:2004-2010, 2003
28. Choy H, Curran WJ, Scott CB, et al: Preliminary report of Locally Advanced Multimodality Protocol (LAMP): ACR 427: A randomized phase II study of three chemo-radiation regimens with paclitaxel, carboplatin and thoracic radiation (TRT) for patients with locally advanced non small cell lung cancer (LA-NSCLC). Proc Am Soc Clin Oncol 21:291a, 2002 (abstr 1160)